Biodesix, Inc. (BDSX)
23.56
-1.15
(-4.65%)
USD |
NASDAQ |
Oct 16, 16:00
23.56
0.00 (0.00%)
After-Hours: 19:01
Biodesix SG&A Expense (TTM) : 93.23M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 93.23M |
| March 31, 2026 | 91.36M |
| December 31, 2025 | 87.54M |
| September 30, 2025 | 84.79M |
| June 30, 2025 | 83.09M |
| March 31, 2025 | 80.34M |
| December 31, 2024 | 80.45M |
| September 30, 2024 | 76.48M |
| June 30, 2024 | 71.96M |
| March 31, 2024 | 68.95M |
| December 31, 2023 | 67.39M |
| September 30, 2023 | 67.76M |
| June 30, 2023 | 67.38M |
| March 31, 2023 | 65.96M |
| Date | Value |
|---|---|
| December 31, 2022 | 61.46M |
| September 30, 2022 | 58.39M |
| June 30, 2022 | 56.89M |
| March 31, 2022 | 53.08M |
| December 31, 2021 | 50.52M |
| September 30, 2021 | 49.02M |
| June 30, 2021 | 43.30M |
| March 31, 2021 | 38.70M |
| December 31, 2020 | 34.86M |
| September 30, 2020 | 29.35M |
| June 30, 2020 | 29.68M |
| March 31, 2020 | 22.85M |
| December 31, 2019 | 14.77M |
| September 30, 2019 | 8.212M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Quest Diagnostics, Inc. | 2.038B |
| Labcorp Holdings, Inc. | 2.219B |
| OPKO Health, Inc. | 205.85M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 359.09M |